Synucleinopathies and their laboratory bio markers

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F21%3AA2202CPI" target="_blank" >RIV/61988987:17110/21:A2202CPI - isvavai.cz</a>

Výsledek na webu

<a href="https://www.csnn.eu/casopisy/ceska-slovenska-neurologie/2021-6-7/synukleinopatie-a-jejich-laboratorni-bio-markery-129374" target="_blank" >https://www.csnn.eu/casopisy/ceska-slovenska-neurologie/2021-6-7/synukleinopatie-a-jejich-laboratorni-bio-markery-129374</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.48095/cccsnn2021535" target="_blank" >10.48095/cccsnn2021535</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Synucleinopathies and their laboratory bio markers

Popis výsledku v původním jazyce

Neurodegenerative diseases represent a large and heterogeneous group of disorders. Their common feature is the deposition of a certain pathological protein in brain tissue. The location and distribution of abnormally constituted alpha-synuclein deposits in central and peripheral nervous system define each respective disorder. The location and distribution of a-synuclein deposits define each respective disorder. Synucleinopathies currently include Parkinson's disease, Parkinson's disease with dementia, Lewy body dementia, multiple system atrophy, pure autonomic failure, and idiopathic REM sleep disorder. The detection of a-synuclein alone in these diseases has the effect in differentiating them from other neurodegenerative diseases; however, its specificity in the differential dia gnosis of individual synucleinopathies is relatively low. Therefore, it is necessary to look for other dia gnostic bio markers that would contribute to the early and accurate dia gnosis of individual diseases. At the same time, it is not just a matter of looking for new markers, but also of looking for more available bio logical samples or body fluids in which these bio markers can be eff ectively detected. In the introduction of this review there is a brief description of each disorder and subsequently there is a brief overview of mostly diagnostic laboratory biomarkers. We first present the cerebrospinal fl uid bio markers that refl ect the direct neuropathological changes, and then several bio markers found in peripheral tissues.

Název v anglickém jazyce

Synucleinopathies and their laboratory bio markers

Popis výsledku anglicky

Neurodegenerative diseases represent a large and heterogeneous group of disorders. Their common feature is the deposition of a certain pathological protein in brain tissue. The location and distribution of abnormally constituted alpha-synuclein deposits in central and peripheral nervous system define each respective disorder. The location and distribution of a-synuclein deposits define each respective disorder. Synucleinopathies currently include Parkinson's disease, Parkinson's disease with dementia, Lewy body dementia, multiple system atrophy, pure autonomic failure, and idiopathic REM sleep disorder. The detection of a-synuclein alone in these diseases has the effect in differentiating them from other neurodegenerative diseases; however, its specificity in the differential dia gnosis of individual synucleinopathies is relatively low. Therefore, it is necessary to look for other dia gnostic bio markers that would contribute to the early and accurate dia gnosis of individual diseases. At the same time, it is not just a matter of looking for new markers, but also of looking for more available bio logical samples or body fluids in which these bio markers can be eff ectively detected. In the introduction of this review there is a brief description of each disorder and subsequently there is a brief overview of mostly diagnostic laboratory biomarkers. We first present the cerebrospinal fl uid bio markers that refl ect the direct neuropathological changes, and then several bio markers found in peripheral tissues.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30103 - Neurosciences (including psychophysiology)

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE

ISSN

1210-7859

e-ISSN

1802-4041

Svazek periodika

84

Číslo periodika v rámci svazku

6

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

5

Strana od-do

535-539

Kód UT WoS článku

000748805900001

EID výsledku v databázi Scopus

—